Tsuzuki Shunsuke, Park Sun Hee, Eber Matthew R, Peters Christopher M, Shiozawa Yusuke
Department of Cancer Biology and Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Int J Urol. 2016 Oct;23(10):825-832. doi: 10.1111/iju.13170. Epub 2016 Aug 3.
As a result of significant improvements in current therapies, the life expectancy of cancer patients with bone metastases has dramatically improved. Unfortunately, these patients often experience skeletal complications that significantly impair their quality of life. The major skeletal complications associated with bone metastases include: cancer-induced bone pain, hypercalcemia, pathological bone fractures, metastatic epidural spinal cord compression and cancer cachexia. Once cancer cells invade the bone, they perturb the normal physiology of the marrow microenvironment, resulting in bone destruction, which is believed to be a direct cause of skeletal complications. However, full understanding of the mechanisms responsible for these complications remains unknown. In the present review, we discuss the complications associated with bone metastases along with matched conventional therapeutic strategies. A better understanding of this topic is crucial, as targeting skeletal complications can improve both the morbidity and mortality of patients suffering from bone metastases.
由于当前治疗方法的显著改进,伴有骨转移的癌症患者的预期寿命已大幅提高。不幸的是,这些患者经常经历严重损害其生活质量的骨骼并发症。与骨转移相关的主要骨骼并发症包括:癌性骨痛、高钙血症、病理性骨折、转移性硬膜外脊髓压迫和癌症恶病质。一旦癌细胞侵入骨骼,它们就会扰乱骨髓微环境的正常生理功能,导致骨质破坏,这被认为是骨骼并发症的直接原因。然而,对这些并发症的发病机制仍不完全清楚。在本综述中,我们讨论了与骨转移相关的并发症以及相应的传统治疗策略。更好地理解这一主题至关重要,因为针对骨骼并发症可以改善骨转移患者的发病率和死亡率。